These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2741811)

  • 61. Clinical, angiographic, and electrophysiologic findings in patients with aborted sudden death as compared with patients with sustained ventricular tachycardia after myocardial infarction.
    Stevenson WG; Brugada P; Waldecker B; Zehender M; Wellens HJ
    Circulation; 1985 Jun; 71(6):1146-52. PubMed ID: 3995708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias.
    Powell AC; Gold MR; Brooks R; Garan H; Ruskin JN; McGovern BA
    Ann Intern Med; 1992 Mar; 116(5):382-7. PubMed ID: 1736771
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
    Ruder MA; Ellis T; Lebsack C; Mead RH; Smith NA; Winkle RA
    J Am Coll Cardiol; 1989 Jan; 13(1):145-52. PubMed ID: 2909562
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia.
    Ho DS; Zecchin RP; Richards DA; Uther JB; Ross DL
    Lancet; 1994 Jul; 344(8914):18-23. PubMed ID: 7912296
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction.
    Kron IL; Lerman B; DiMarco JP
    Ann Thorac Surg; 1986 Jul; 42(1):13-6. PubMed ID: 3729611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metoprolol versus sotalol in the treatment of sustained ventricular tachycardia.
    Antz M; Cappato R; Kuck KH
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):627-35. PubMed ID: 8569226
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias.
    Hohnloser SH; Raeder EA; Podrid PJ; Graboys TB; Lown B
    Am Heart J; 1987 Jul; 114(1 Pt 1):1-7. PubMed ID: 3604854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term arrhythmic outcome in survivors of ventricular fibrillation with absence of inducible ventricular tachycardia.
    Zheutlin TA; Steinman RT; Mattioni TA; Kehoe RF
    Am J Cardiol; 1988 Dec; 62(17):1213-7. PubMed ID: 3195483
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Signal-averaged electrocardiographic late potentials in patients with ventricular fibrillation or ventricular tachycardia: correlation with clinical arrhythmia and electrophysiologic study.
    Freedman RA; Gillis AM; Keren A; Soderholm-Difatte V; Mason JW
    Am J Cardiol; 1985 May; 55(11):1350-3. PubMed ID: 3993568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Myocardial lactate extraction during programmed ventricular stimulation and its value for etiologically-related therapy of ischemic ventricular tachyarrhythmia].
    Vester EG; Perings C; Kuhls S; Ochiulet-Vester J; Strauer BE
    Z Kardiol; 1995 Jun; 84(6):443-58. PubMed ID: 7653084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Electrophysiologic characteristics of ventricular tachycardia or fibrillation in relation to age of myocardial infarction.
    Stevenson WG; Brugada P; Kersschot I; Waldecker B; Zehender M; Geibel A; Wellens HJ
    Am J Cardiol; 1986 Feb; 57(6):387-91. PubMed ID: 3946252
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Results of electrophysiologically guided operations for drug-resistant recurrent ventricular tachycardia and ventricular fibrillation due to coronary artery disease.
    Brodman R; Fisher JD; Johnston DR; Kim SG; Matos JA; Waspe LE; Scavin GM; Furman S
    J Thorac Cardiovasc Surg; 1984 Mar; 87(3):431-8. PubMed ID: 6700249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potential proarrhythmic effect of biventricular pacing: fact or myth?
    Shukla G; Chaudhry GM; Orlov M; Hoffmeister P; Haffajee C
    Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relation of acute antiarrhythmic drug efficacy to left ventricular function in coronary artery disease.
    Meissner MD; Kay HR; Horowitz LN; Spielman SR; Greenspan AM; Kutalek SP
    Am J Cardiol; 1988 May; 61(13):1050-5. PubMed ID: 3284319
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction.
    Bhandari AK; Au PK; Rose JS; Kotlewski A; Blue S; Rahimtoola SH
    Am J Cardiol; 1987 Feb; 59(4):284-90. PubMed ID: 3812277
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy.
    Milner PG; Dimarco JP; Lerman BB
    Pacing Clin Electrophysiol; 1988 May; 11(5):562-8. PubMed ID: 2456534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
    Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB
    Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease.
    Winters SL; Kukin M; Pe E; Stewart D; Deitchman D; Gomes JA
    Am J Cardiol; 1993 Aug; 72(4):38A-43A. PubMed ID: 8346725
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determinants of arrhythmogenic ventricular activity detected on the body surface QRS in patients with coronary artery disease.
    Denes P; Uretz E; Santarelli P
    Am J Cardiol; 1984 Jun; 53(11):1519-23. PubMed ID: 6731295
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Utility of the signal-averaged electrocardiogram in patients presenting with sustained ventricular tachycardia or fibrillation while on an antiarrhythmic drug.
    Nalos PC; Gang ES; Mandel WJ; Myers MR; Oseran DS; Lass Y; Peter T
    Am Heart J; 1988 Jan; 115(1 Pt 1):108-14. PubMed ID: 3336965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.